Germinal matrix hemorrhage remains the leading cause of morbidity and mortality in preterm infants in the United States with little progress made in its clinical management. Survivors are often afflicted with long-term neurological sequelae, including cerebral palsy, mental retardation, hydrocephalus, and psychiatric disorders. Blood clots disrupting normal cerebrospinal fluid circulation and absorption after germinal matrix hemorrhage are thought to be important contributors towards post-hemorrhagic hydrocephalus development. We evaluated if upregulating CD36 scavenger receptor expression in microglia and macrophages through PPARγ stimulation, which was effective in experimental adult cerebral hemorrhage models and is being evaluated clinically, will enhance hematoma resolution and ameliorate long-term brain sequelae using a neonatal rat germinal matrix hemorrhage model. PPARγ stimulation (15d-PGJ 2 ) increased short-term PPARγ and CD36 expression levels as well as enhanced hematoma resolution, which was reversed by a PPARγ antagonist (GW9662) and CD36 siRNA. PPARγ stimulation (15d-PGJ 2 ) also reduced long-term white matter loss and post-hemorrhagic ventricular dilation as well as improved neurofunctional outcomes, which were reversed by a PPARγ antagonist (GW9662). PPARγ-induced upregulation of CD36 in macrophages and microglia is, therefore, critical for enhancing hematoma resolution and ameliorating long-term brain sequelae.
Introduction
The ganglionic eminence consists of neuronal and glial precursor cells located at the head of the caudate nucleus below the lateral ventricles of the developing fetus, and the highly vascularized region within the subependymal tissue is the germinal matrix. Cerebral blood flow fluctuation associated with hemodynamic and respiratory instability in preterm infants in conjunction with the inherent fragility of the germinal matrix often leads to germinal matrix hemorrhage, a very common and major neurological complication of prematurity. Germinal matrix hemorrhage (GMH) occurs when immature blood vessels rupture within the subependymal (or periventricular) germinal region of the ganglionic eminence in the immature brain (Ballabh, 2010) . In the United States alone, GMH occurs in approximately 12,000 lives births per year, and the number of moderate-to-severe GMH cases has remained steady over the past two decades (Fanaroff et al., 2007; Jain et al., 2009; Osterman et al., 2015) . Clinical studies indicate GMH afflicted infants often suffer from long-term neurological deficits, cerebral palsy, mental retardation, hydrocephalus, and psychiatric disorders (Ballabh, 2014; Kadri et al., 2006) . Prenatal glucocorticoid treatment remains the best treatment for preventing GMH, yet minimal advancements have been made in GMH clinical management post-ictus (Roberts and Dalziel, 2006; Shankaran et al., 1995) .
Hemodynamic and respiratory instability in preterm infants results in fluctuations of cerebral blood flow in the inherently frail germinal matrix vasculature, often resulting in spontaneous bleeding (Ballabh, 2014) . The consequent hematoma applies mechanical pressure to glia and neurons, resulting in cytotoxicity and necrosis, as well as evokes an inflammatory response, leading to secretion of destructive proteases and oxidative species (Lekic et al., 2015) . In adult cerebral hemorrhage, clinical studies indicate hematoma volume is the best prognostic indicator; larger hematoma volumes have worsened outcomes (Keep et al., 2005; Xi et al., 2006) . Experimental adult cerebral hemorrhage studies proved more rapid hematoma resolution is necessary for quickly ameliorating inflammation and improving neurological recovery (Zhao et al., 2007 (Zhao et al., , 2009 . Additionally, blood clots directly impair cerebrospinal fluid circulation and absorption after GMH, significantly contributing towards post-hemorrhagic hydrocephalus development (Aquilina et al., 2011; Cherian et al., 2004) . Therefore, we hypothesize enhancing hematoma resolution will improve GMH outcomes. 
